| Entrez gene ID | | 1565 |
|
| Official gene symbol | | CYP2D6 |
|
| Full name | | cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
| Aliases | | ,CPD6,CYP2D,CYP2D7AP,CYP2D7BP,CYP2D7P2,CYP2D8P2,CYP2D@,CYP2DL1,MGC120389,MGC120390,P450-DB1,P450C2D,P450DB1, |
|
| Gene summary | | This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 20% of commonly prescribed drugs. Its substrates include debrisoquine, an adrenergic-blocking drug; sparteine and propafenone, both anti-arrythmic drugs; and amitryptiline, an anti-depressant. The gene is highly polymorphic in the population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. The gene is located near two cytochrome P450 pseudogenes on chromosome 22q13.1. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq] |
|
| Location | | Chromosome: 22 Locus: 22q13.1 |
|
| Gene position | | 42526883 - 42522501 Map Viewer |
|
| Gene orientation | | minus |
|
| Gene size | | 4383 bp |
|
| Gene sequence |
| |
|
| OMIM ID | | 124030 |
|
|
|
